- Home
- MEOH vs LGND Comparison
MEOH vs LGND Comparison
Compare MEOH & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MEOH | LGND |
|---|---|---|
| Founded | 1968 | 1987 |
| Country | Canada | United States |
| Employees | N/A | 68 |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | MEOH | LGND |
|---|---|---|
| Price | $48.68 | $315.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $58.33 | ★ $256.29 |
| AVG Volume (30 Days) | ★ 989.0K | 496.6K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.17% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.43 | $1.25 |
| Revenue Next Year | N/A | $19.41 |
| P/E Ratio | ★ $16.44 | $76.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.00 | $122.34 |
| 52 Week High | $66.75 | $326.63 |
Technical Indicators
Market Signals| Indicator | MEOH | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 41.95 | 67.37 |
| Support Level | $47.15 | $180.85 |
| Resistance Level | $51.94 | N/A |
| Average True Range (ATR) | 1.74 | 14.06 |
| MACD | 0.25 | 0.47 |
| Stochastic Oscillator | 49.65 | 81.98 |
Price Performance
Historical ComparisonAbout MEOH Methanex Corporation
Methanex Corp operates as a producer and supplier of methanol to various international markets in North America, Asia Pacific, Europe and South America. The company's operations consist prominently of the production and sale of methanol, along with the production and sale of ammonia. Geographically, it operates in China, Europe, the United States, South America, South Korea, Other Asia, and Canada. The majority of revenue is derived from Europe.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.